Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14.
Japanese encephalitis virus (JEV), a neuroinvasive and neurovirulent orthoflavivirus, can be prevented in humans with the SA14-14-2 vaccine, a live-attenuated version derived from the wild-type SA14 strain. To determine the viral factors responsible for the differences in pathogenicity between SA14...
Saved in:
| Main Authors: | Byung-Hak Song, Sang-Im Yun, Joseph L Goldhardt, Jiyoun Kim, Young-Min Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1012844 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
by: Susan L Hills, et al.
Published: (2022-01-01) -
Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
by: Lance Turtle, et al.
Published: (2017-01-01) -
Long-term immunogenicity of the SA14-14-2 Japanese encephalitis (JE) vaccine (CD.JEVAX®) booster following chimeric JE (IMOJEV®) vaccine priming in Thai children
by: Tawee Chotpitayasunondh, et al.
Published: (2024-12-01) -
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14.
by: Ron A-J Chen, et al.
Published: (2008-02-01) -
Host-mimicking conditions promote Pseudomonas aeruginosa PA14 virulence gene expression
by: Amber Grace, et al.
Published: (2025-04-01)